摘要
目的：探讨糖尿病视网膜病变与诱导型一氧化氮合酶的表达的关系并探讨舒唐络复方对诱导型一氧化氮合酶表达的影响以及对糖尿病视网膜病变的防治作用。方法：雄性SD大鼠70只随机分成对照组10只，糖尿病1月、3月、6月组以及舒唐络复方干预3月、6月组各12只。分别留取视网膜标本，部分标本观测视网膜病理改变；部分标本采用免疫组化法测定诱导型一氧化氮合酶表达。结果：视网膜病理结果显示：与正常对照组相比，糖尿病1月、3月、6月组视网膜病理改变逐步加重；免疫组化分析结果显示诱导型一氧化氮合酶表达在糖尿病各组均明显增强（P均〈0．05），干预组较糖尿病各组均有明显改善（P均〈0．05）。结论：糖尿病视网膜病变早期就出现视网膜诱导型一氧化氮合酶表达增强，且随着视网膜组织病理学改变而持续活化。舒唐络复方有效抑制了诱导型一氧化氮合酶表达，从而达到视网膜保护的目的。
Objective： To investigate the expression of retina inducible isoform of nitric oxide synthase （iNOS） at different stage of diabetic rats and the effects of Shutangluo compound on diabetic retinopathy. Methods： Seventy sprague-dawley rats were randomly divided into control group, diabetic group and Shutang Luo compound treatment group. Diabetic model of rat was induced by injecting streptozotocin （STZ）. The morphology in retinal paraffin slide was observed by microscope. The expression of iNOS was detected by immunohistochemistry. Results： Histopathology was detected at 3 months. The change of histopathology is severe at 6 months than at 3 months.1 months of diabetes in rats resulted in retinal iNOS activation （as detected by immunohistochemistry）, and iNOS remained activated at 3 and 6 months of diabetes. Shutang Luo inhibited elevations of iNOS expression, without ameliorating the severity of hyperglycemia. Conclusion： iNOS is activated in retina in diabetes before histopathology can be seen, and remains activated for the duration when the retinopathy is developing. Shutang Luo fang might be inhibiting the development of retinopathy by inhibiting iNOS activation.
出处
《中医临床研究》
2010年第21期10-12,共3页
Clinical Journal Of Chinese Medicine
基金
江苏省科技厅社会发展项目BS2007091.
关键词
舒唐络复方
视网膜
糖尿病
诱导型一氧化氮合酶
Shutang Luo
Retina
Diabetes
Inducible isoform of nitric oxide synthase （iNOS）
